Regen BioPharma

(RGBPP)

By |

Profile

Regen BioPharma Inc is a US-based Biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.

Contact Information

Website: www.regenbiopharma.com
Main Phone: +1 619 702-1404
Address: 4700 Spring Street
Address 2: Suite 304
State: CA
City / Town: La Mesa
Country: USA
Postal Code: 91942

Issuer Information

Exchange: OTCQB
CEO: David R. Koos
Employees: 4
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.0053 $ 0.0001 (1.92%)
Last Price 0.0053 Change $ 0.0001 Change % 1.92 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0053 High 0.0053 Low 0.0053 Prev Close 0.0052
Last Trade Volume 13,046 52 Wk Hi 0.075 52 Wk Low 0.0023
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange OTCQB